Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda. 

Ndashimye, E., Avino, M., Olabode, A. S., Poon, A. F., Gibson, R. M., Li, Y., ... & Arts, E. J